MKC-1 structure
|
Common Name | MKC-1 | ||
---|---|---|---|---|
CAS Number | 125313-92-0 | Molecular Weight | 400.38700 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H16N4O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of MKC-1MKC-1 (Ro-31-7453) is an orally active and potent cell cycle inhibitor with broad antitumor activity. MKC-1 inhibits the Akt/mTOR pathway. MKC-1 arrests cellular mitosis and induces cell apoptosis by binding to a number of different cellular proteins including tubulin and members of the importin β family[1][2][3]. |
Name | 3-(1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione |
---|---|
Synonym | More Synonyms |
Description | MKC-1 (Ro-31-7453) is an orally active and potent cell cycle inhibitor with broad antitumor activity. MKC-1 inhibits the Akt/mTOR pathway. MKC-1 arrests cellular mitosis and induces cell apoptosis by binding to a number of different cellular proteins including tubulin and members of the importin β family[1][2][3]. |
---|---|
Related Catalog | |
In Vivo | MKC-1 (200 mg/kg, orally, daily) significantly increased the median survival time (MST) of mice bearing Caki-1 renal cell xenograft tumors[3]. |
References |
Molecular Formula | C22H16N4O4 |
---|---|
Molecular Weight | 400.38700 |
Exact Mass | 400.11700 |
PSA | 105.34000 |
LogP | 3.94450 |
MKC-1 |
UNII-DNZ11VPY7Q |
Bisindolylmaleimide deriv. 44 |
3-(1-methyl-3-indolyl)-4-(1-methyl-6-nitro-3-indolyl)-1H-pyrrole-2,5-dione |
Ro-31-7453 |